Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus
Status:
Terminated
Trial end date:
2012-02-23
Target enrollment:
Participant gender:
Summary
The research trial is testing the experimental drug pimasertib and the drug Torisel, given
together, in the treatment of advanced solid tumors. The primary purpose of the study is to
determine the maximum tolerated dose (MTD) and the recommended Phase 2 dose (RP2D) of the
drug combination.